tirzepatide pris - Treatment Plan & Guidelines for Optimal Results Tirzepatide – 5mg – Prime

According to FDA prescribing information, these effects vary by product and dose: For Ozempic (diabetes treatment): Nausea (15-20% of patients) Diarrhea (8-9% of patients) Vomiting (5-9% of patients) Constipation (3-7% of patients) Abdominal pain (5-6% of patients) For Wegovy (weight management), gastrointestinal effects are more common at the higher therapeutic dose: Nausea (up to 44% of patients) Diarrhea (up to 30% of patients) Vomiting (up to 24% of patients) Constipation (up to 24% of patients) Abdominal pain (up to 20% of patients) These effects are generally mild to moderate and tend to diminish with continued use

One 12-week study about the safety of tesamorelin for patients with type 2 diabetes found that it had no effect on glycemic control and did not alter insulin response [14]

Furthermore, clinicians should consider individual patient factors

*% Daily Value (DV): Not established

GLP-1 weight loss uses a class of medications that mimic GLP-1, a natural gut hormone that helps regulate appetite, blood sugar, and digestion

Retrieved 17 June 2026